Article in PLoS genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors at 12 institutions in 1 country.
Jenil PatelDepartment of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.ORCID 0000-0002-4875-7390
Emine BircanDepartment of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.ORCID 0000-0003-2527-3470
Xinyu TangBiostatistics Program, Department of Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Arkansas Children's Research Institute, Little Rock, AR, United States of America.
Mohammed OrloffDepartment of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.ORCID 0000-0002-5920-0627
Charlotte A HobbsRady Children's Institute for Genomic Medicine, San Diego, CA, United States of America.
Marilyn L BrowneBirth Defects Research Section, New York State Department of Health, Albany, NY, United States of America.ORCID 0000-0002-1872-2787
Lorenzo D BottoDivision of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, UT, United States of America.ORCID 0000-0002-5322-7116
Richard H FinnellDepartment of Molecular and Cellular Biology, Center for Precision Environmental Health, Baylor College of Medicine, Houston, TX, United States of America.
Mary M JenkinsNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.ORCID 0000-0002-4399-1348
Andrew OlshanDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Paul A RomittiDepartment of Epidemiology, College of Public Health, The University of Iowa, Iowa City, IA, United States of America.ORCID 0000-0001-5393-9984
Gary M ShawDivision of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, United States of America.ORCID 0000-0001-7438-4914
Martha M WerlerDepartment of Epidemiology, School of Public Health, Boston University, Boston, MA, United States of America.
Jingyun LiBiostatistics Program, Department of Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Arkansas Children's Research Institute, Little Rock, AR, United States of America.ORCID 0000-0002-2526-9052
Wendy N NembhardDepartment of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.
National Birth Defects Prevention Study
University of Arkansas for Medical Sciences · USArkansas Children's Hospital · USCenters for Disease Control and Prevention · USBaylor College of Medicine · USBoston University · USChildren’s Institute · USNew York State Department of Health · USStanford University · USUniversity of Iowa · USUniversity of North Carolina at Chapel Hill · USUniversity of Texas Health Science Center at Dallas · USUniversity of Utah · US
Funding
Translational Research Support CoreP30ES030285 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI Casey W Wright · 2019 to 2026
$14.7M
Genomic/Epigenomic Factors and Non-Syndromic Congenital Heart Defect Risk R01HD039054 · NICHD · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI HOBBS, CHARLOTTE A · 2000 to 2016
$13.6M
RFA-DD-18-001 Birth Defects Study To Evaluate Pregnancy exposures (BD-STEPS) II Core & Component B Steps -StillbirthU01DD001285 · DD · UNIV OF ARKANSAS FOR MED SCIS · PI NEMBHARD, WENDY N · 2019 to 2022
$5.2M
New York State Component A: BD-STEPS II CoreU01DD001227 · DD · CENTER OF ENVIRONMENTAL HEALTH · PI HOWLEY, MEREDITH M · 2018 to 2022
$4.2M
Birth Defects Study To Evaluate Pregnancy exposureSU01DD001039 · DD · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI NEMBHARD, WENDY N · 2013 to 2017
$4.2M
CALIFORNIA CENTER OF BD-STEPS II FINDING CAUSES AND PREVENTIVES OF BIRTH DEFECTSU01DD001226 · DD · STANFORD UNIVERSITY · PI SHAW, GARY M · 2018 to 2022
$4.0M
Expanding Translational Research in ArkansasU54TR001629 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI JAMES, LAURA P · 2017 to 2017
$3.5M
Component A: Arkansas Proposal to participate in the Birth Defects Study to Evaluate Pregnancy exposureS (BD-STEPS II)U01DD001229 · DD · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI NEMBHARD, WENDY N · 2018 to 2018
Previous research on risk factors for obstructive heart defects (OHDs) focused on maternal and infant genetic variants, prenatal environmental exposures, and their potential interaction effects. Less is known about the role of paternal genetic variants or environmental exposures and risk of OHDs. We examined parent-of-origin effects in transmission of alleles in the folate, homocysteine, or transsulfuration pathway genes on OHD occurrence in offspring. We used data on 569 families of liveborn infants with OHDs born between October 1997 and August 2008 from the National Birth Defects Prevention Study to conduct a family-based case-only study. Maternal, paternal, and infant DNA were genotyped using an Illumina Golden Gate custom single nucleotide polymorphism (SNP) panel. Relative risks (RR), 95% confidence interval (CI), and likelihood ratio tests from log-linear models were used to estimate the parent-of-origin effect of 877 SNPs in 60 candidate genes in the folate, homocysteine, and transsulfuration pathways on the risk of OHDs. Bonferroni correction was applied for multiple testing. We identified 3 SNPs in the transsulfuration pathway and 1 SNP in the folate pathway that were statistically significant after Bonferroni correction. Among infants who inherited paternally-derived copies of the G allele for rs6812588 in the RFC1 gene, the G allele for rs1762430 in the MGMT gene, and the A allele for rs9296695 and rs4712023 in the GSTA3 gene, RRs for OHD were 0.11 (95% CI: 0.04, 0.29, P = 9.16x10-7), 0.30 (95% CI: 0.17, 0.53, P = 9.80x10-6), 0.34 (95% CI: 0.20, 0.57, P = 2.28x10-5), and 0.34 (95% CI: 0.20, 0.58, P = 3.77x10-5), respectively, compared to infants who inherited maternally-derived copies of the same alleles. We observed statistically significant decreased risk of OHDs among infants who inherited paternal gene variants involved in folate and transsulfuration pathways.
Indexed as
Genetic Predisposition to DiseaseGenetic VariationInheritance PatternsAdultAllelesCardiomyopathy, Hypertrophic, FamilialChromosome MappingFemaleGenotypeHeart Defects, CongenitalHumansMaleMiddle AgedOdds RatioPhenotypePolymorphism, Single Nucleotide
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Paternal genetic variants and risk of obstructive heart defects: A parent-of-origin approach. · full record | OpenQuestion